Search contract descriptions, companies and agencies.
US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Total Committed
$354M
Product or Service Description
Commercialized Biomedical R&D
Total Potential Value
$812M
Contracting Agency
Effective Date
May 18, 2020
Funding Department
OFFICE OF ACQ&MGMT POLICY
Type
Cost plus fixed fee
Solicitation Procedure
Only one source
Extent Competed
Not competed
Reason
Mobilization, Essential R&D (Far 6.302 3)
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| PHLOW CORP. | US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS. | May 18, 2020 | $354,256,000 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.